865106-60-1

Basic information

• Product Name: Tert-butyl 3-(2-ethoxy-2-oxoethylidene)-8-azabicyclo[3.2.1]octane-8-carboxylate
• Synonyms: 865106-60-1;tert-butyl 3-(2-ethoxy-2-oxoethylidene)-8-azabicyclo[3.2.1]octane-8-carboxylate;tert-butyl 3-ethoxycarbonylmethylene-8-aza-bicyclo[3.2.1]octane-8-carboxylate;SCHEMBL4087723;GEMJVWXRPBJSJH-UHFFFAOYSA-N;AS-73680;CS-0456622;8-Boc-3-ethoxycarbonylmethylene-8-aza-bicyclo[3.2.1]octane;3-ethoxycarbonylmethylene-8-azabicyclo[3.2.1]octane-8-carb oxylic acid tert-butyl ester;3-Ethoxycarbonylmethylene-8-azabicyclo[3.2.1]octane-8-carboxylic acid t-butyl ester;3-ethoxycarbonylmethylene-8-azabicyclo[3.2.1]octane-8-carboxylic acid tert-butyl ester;tert-butyl 3-ethoxycarbonylmethylene-8-azabicyclo[3.2.1]octane-8-carboxylate
• CAS NO: 865106-60-1
• Molecular Weight: 295.379
• Mol File: 865106-60-1.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: Tert-butyl 3-(2-ethoxy-2-oxoethylidene)-8-azabicyclo[3.2.1]octane-8-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: Tert-butyl 3-(2-ethoxy-2-oxoethylidene)-8-azabicyclo[3.2.1]octane-8-carboxylate(865106-60-1)
• EPA Substance Registry System: Tert-butyl 3-(2-ethoxy-2-oxoethylidene)-8-azabicyclo[3.2.1]octane-8-carboxylate(865106-60-1)

Safety Data

• Hazardous Substances Data: 865106-60-1(Hazardous Substances Data)

Upstream product

• 867-13-0 diethoxyphosphoryl-acetic acid ethyl ester 
• 185099-67-6 Boc-tropinone 

Downstream Products

• 79521-85-0 ethyl 2-(8-benzyl-8-azabicyclo[3.2.1]octan-3-ylidene)acetate 
• 1188414-77-8 2-(8-benzyl-8-azabicyclo[3.2.1]octan-3-ylidene)-N-hydroxyacetamide 
• 257628-75-4 3-{2-[(2-Iodo-phenyl)-(2,2,2-trifluoro-acetyl)-amino]-ethylidene}-8-aza-bicyclo[3.2.1]octane-8-carboxylic acid tert-butyl ester 

Relevant articles and documents

ATX MODULATING AGENTS

Compounds of formula (I) can modulate the activity of autotaxin (ATX).

Tetrahydroquinoline analogues as muscarinic agonists

The present invention relates to tetrahydroquinoline compounds as muscarinic receptor agonists; compositions comprising the same; methods of inhibiting an activity of a muscarinic receptor with said compounds; methods of treating a disease condition associated with a muscarinic receptor using said compounds; and methods for identifying a subject suitable for treatment using said compounds.